See below for MAPS Public Benefit Corporation staff
Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master's thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and three children.
Merete received her BS in Biology at the State University of New York at Geneseo, where she developed her passion for community service and activism. She furthered these interests working with High Trails Outdoor Science School following her undergraduate studies. Merete is passionate about learning, reading, yoga, and the dissemination of information. She is thrilled to have the opportunity to contribute to the MAPS mission.
Natalie earned her Master’s in Social Work from Columbia University in 2014, and her Bachelor's in History from Yale University in 2011. At Columbia, Natalie served as a Policy Fellow at the Drug Policy Alliance, where she helped legalize medical marijuana in her home state of New York, and worked to end New York’s racist marijuana arrests. Natalie has also worked as a court-mandated therapist for individuals arrested for prostitution and drug-related offenses, and as a middle school guidance counselor at an NYC public school. Natalie’s clinical work with trauma survivors spurred her interest in psychedelic-assisted therapy, which she believes can ease a wide variety of both mental and physical ailments by addressing the root cause of individuals’ difficulties, rather than their symptoms. Through her work at MAPS, Natalie advocates for unbiased research to help undermine both the war on drugs and the current mental health paradigm.
Ifetayo comes to MAPS with a degree in History and African Studies from Smith College, where she was awarded Outstanding Student Leader of the Year in 2014. Prior to MAPS, Ifetayo interned at the Drug Policy Alliance in 2013. Ifetayo spoke publicly about her experience growing up with an incarcerated parent in hopes of bringing an end to racist drug policies and mass incarceration in the opening plenary of the 2013 International Drug Policy Reform Conference and on NPR’s All Things Considered. Ifetayo's work has been featured in The Huffington Post, Alternet, and other media. At MAPS, Ifetayo works as Executive Assistant to Rick Doblin, assisting with e-mail and social media communications, travel, speaking engagements, and administrative support.
Bryce studied film production at West Valley College, where he also developed an interest in marketing. Bryce joined MAPS as a Social Media Intern in the summer of 2011, bringing his background in film production and social media to public education about psychedelics. After interning at MAPS for a year, Bryce now serves as Web and Multimedia Manager, a position that combines all of his passions; ranging from using the internet to reach people worldwide to creating visually stimulating media projects.
Linnae earned her BA in Biological Psychology from New College of Florida where she defended her thesis, which investigated the impact of sleep disturbance in the pathogenesis of depression in a sample of 360 students. Linnae oversees MAPS' harm reduction program, the Zendo Project, and has traveled internationally to coordinate and train volunteers to offer psychological support to individuals having difficult psychedelic experiences, in order to reduce the number of drug-related hospitalizations and arrests. For Linnae, psychedelic harm reduction is an essential service for festivals, capable of transforming potentially traumatic experiences into opportunities for growth and showing that safe, expansive experiences are possible without the need for law enforcement-based policies. She is currently completing her Master's in Counseling Psychology at CIIS and is a co-therapist intern in MAPS' MDMA-assisted psychotherapy for anxiety associated with life-threatening illness study in Marin, CA.
Jade Netanya Ullmann is a seasoned fundraiser, philanthropist, activist, and community organizer. She is the former executive director of Romemu, a progressive Jewish spiritual community in New York City. Jade is an ambassador for the Social Venture Network, a nonprofit network of business leaders committed to justice and sustainability, as well as a member of the Threshold Foundation, which is dedicated to mobilizing financial resources to change the world. She currently serves on the Board of Directors of Romemu, as well as ALEPH: The Alliance for Jewish Renewal, and on the Advisory Board of Bernie Glassman’s Zen Peacemaker Order. She received her B.A. in contemplative psychology from Naropa University, where she was the campus organizer of Students for a Free Tibet. She began working with MAPS in early 2015 to expand the organization’s community visibility, and has since joined the staff as Major Gifts Officer. Jade is enthusiastic about inspiring others to recognize and support the visionary research and healing work of MAPS. She lives in New York City, where she was born and raised.
See above for MAPS 501(c)(3) Staff
Amy earned her BS in genetics and cell biology from Washington State University in 1992. Prior to her work at the Multidisciplinary Association for Psychedelic Studies (MAPS) and MAPS Public Benefit Corporation (MPBC) she worked in clinical development and research beginning in 1993. Amy's previous experience is in the fields of immunology (Applied Immune Sciences), oncology (RPR), and vaccine development (Chiron and Novartis). Amy worked with MAPS as a volunteer starting in 2003 facilitating the development of the MDMA clinical program. In 2009, she began managing the Clinical Research group at MAPS. She is currently the Executive Director and Director of Clinical Research of MAPS Public Benefit Corporation.
Alli assists in coordinating operations at MPBC's multi-site trials, and applies her translational perspective to the development of new study protocols. After earning her Ph.D. in Neuropharmacology from the University of Texas at Austin utilizing rodent models to study the effects of MDMA on behavior and neurochemical release, Alli was a postdoctoral researcher in the Preclinical Development Group at Ernest Gallo Clinic and Research Center at the University of California, San Francisco. At UCSF her experiments focused on novel treatment strategies for alcohol dependence. In 2012, Alli received a Postdoctoral Research Training Award from the National Institutes of Health for work on NIAAA clinical trials investigating novel therapeutics for alcoholism, as well as human fMRI studies of addiction. Recognizing now as a monumental time in history, Alli highly regards the chance to help generate scientifically based evidence on the therapeutic and spiritual potential of psychedelics.
Rebecca earned her BA at UC Berkeley in 2000. Prior to her work at Multidisciplinary Association for Psychedelic Studies (MAPS) and MAPS Public Benefit Corporation (MPBC) she worked in clinical research and development at Chiron/Novartis starting in 2001, working on sepsis and monitoring and managing vaccine trials. In 2009, she joined MAPS as a part-time contractor and has since been working with them on MDMA/PTSD studies. In 2015, Rebecca joined MPBC full-time to work on Marijuana/PTSD studies as well as continuing to support MDMA studies.
Ben received his BA in Psychology from Princeton University in 2009, where his work included research on motor learning in children, investigation of ‘flow state’ phenomena, and a thesis that developed a neuroeconomic framework for understanding the phenomenon of boredom. Following his graduation, Ben spent a year as a Clinical Research Coordinator at a private clinical trials site, working primarily on studies investigating potential treatments for Alzheimer’s Disease. Working in the field of psychedelic research allows Ben to investigate the experience of consciousness from a variety of perspectives—empirical, psychological, spiritual, and phenomenological.
Allison earned her B.S. in Biopsychology in 2014 from Tufts University. She worked in the Tufts Psychopharmacology Lab for three years, conducting data collection and analysis for several projects. Her Senior Honors Thesis focused on the role of the NMDA receptor in mediating aggressive withdrawal symptoms in alcohol-dependent, outbred, male mice. She was also co-president of the Tufts chapter of Students for Sensible Drug Policy (SSDP), where she helped to pass medical amnesty reform on campus and spread awareness of the harmful side effects of the War on Drugs. Allison is currently serving as MAPS’ Clinical Study Assistant, providing general administrative support to the clinical department. She considers working for MAPS to be a dream come true and relishes the opportunity to help deconstruct the damaging, reductionist paradigms of the contemporary mental health care system and to improve access to viable treatment options for those suffering from trauma- and anxiety-related disorders.